Cannabinoid derivatives acting as dual PPARγ/CB2 agonists as therapeutic agents for systemic sclerosis

EDUARDO MUÑOZ BLANCO2026-01-292026-01-29201910.1016/j.bcp.2019.02.0292-s2.0-85062408735https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/28602BiochemistryPharmacologyCannabinoid derivatives acting as dual PPARγ/CB2 agonists as therapeutic agents for systemic sclerosisresearch article